World's Best Scientists 2026 revealed!
Hiroshi Maeda

Hiroshi Maeda

Award Badge
Biology and Biochemistry
Japan
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
125
Citations
90050
World Ranking
498
National Ranking
20

Hiroshi Maeda publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Hiroshi Maeda sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 843 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Hiroshi Maeda D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hiroshi Maeda sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 125 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Japan Leader Award
  • 2025 - Research.com Biology and Biochemistry in Japan Leader Award
  • 2023 - Research.com Biology and Biochemistry in Japan Leader Award

Overview

Hiroshi Maeda is affiliated with Kumamoto University in Japan and specializes in research within materials science, biochemistry, genetics and molecular biology, and engineering. Their work primarily focuses on nanoparticle-based drug delivery, nanoplatforms for cancer theranostics, and fields related to molecular biology and biomedical engineering.

The scientist's publications cover a range of topics, with a significant emphasis on drug delivery systems and nanomedicine. Notable recent papers include:

  • Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers, 2020, Advanced Drug Delivery Reviews
  • The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects, 2021, Journal of Personalized Medicine
  • Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis, 2020, Biomaterials
  • Fibrinolytic tissue plasminogen activator installed redox-active nanoparticles (t-PA@iRNP) for cancer therapy, 2020, Biomaterials
  • Phosphorylcholine-Grafted Molecular Bottlebrush-Doxorubicin Conjugates: High Structural Stability, Long Circulation in Blood, and Efficient Anticancer Activity, 2020, Biomacromolecules

Frequent coauthors who have contributed alongside Hiroshi Maeda include Jun Fang, Waliul Islam, Kazuo Sakurai, Ayaka Harada, and Takuro Niidome. The collaboration network shows repeated partnerships with these researchers, reflecting ongoing cooperative efforts in related areas.

The main publication venues for this researcher are:

  • Journal of Personalized Medicine
  • Biomaterials
  • Advanced Drug Delivery Reviews
  • Biomacromolecules
  • Cancers

Hiroshi Maeda's research fields span multiple sub-disciplines. These include biomaterials, biomedical engineering, molecular biology, materials chemistry, and pulmonary and respiratory medicine. The scientist's main topics center around:

  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Lanthanide and Transition Metal Complexes
  • Heme Oxygenase-1 and Carbon Monoxide
  • Electron Spin Resonance Studies
  • Photodynamic Therapy Research Studies
  • Cancer, Hypoxia, and Metabolism

Best Publications

  • A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs

    Yasuhiro Matsumura;Hiroshi Maeda

  • Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

    H Maeda;J Wu;T Sawa;Y Matsumura

  • A New High-TcOxide Superconductor without a Rare Earth Element

    Hiroshi Maeda;Yoshiaki Tanaka;Masao Fukutomi;Toshihisa Asano

  • The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

    Jun Fang;Hideaki Nakamura;Hiroshi Maeda

  • The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

    Hiroshi Maeda

  • The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

    Hiroshi Maeda;Hideaki Nakamura;Jun Fang

  • Exploiting the enhanced permeability and retention effect for tumor targeting.

    Arun K. Iyer;Greish Khaled;Jun Fang;Hiroshi Maeda

  • Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

    Uma Prabhakar;Hiroshi Maeda;Rakesh K. Jain;Eva M. Sevick-Muraca

  • Genome sequencing and analysis of Aspergillus oryzae

    Masayuki Machida;Kiyoshi Asai;Motoaki Sano;Toshihiro Tanaka

  • Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

    H. Maeda;G.Y. Bharate;J. Daruwalla

  • Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects.

    Hiroshi Maeda

  • Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

    Hiroshi Maeda;Tomohiro Sawa;Toshimitsu Konno

  • Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

    Hiroshi Maeda

  • Sputter deposition of BiSrCaCuO thin films

    Masao Fukutomi;Junichi Machida;Yoshiaki Tanaka;Toshihisa Asano

  • Tumoritropic and lymphotropic principles of macromolecular drugs.

    Maeda H;Matsumura Y

  • Macromolecular therapeutics in cancer treatment: the EPR effect and beyond.

    Hiroshi Maeda

  • Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction.

    Takaaki Akaike;Masaki Yoshida;Yoichi Miyamoto;Keizo Sato

  • Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

    Hiroshi Maeda;Len W. Seymour;Yoichi Miyamoto

  • Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.

    Hiroshi Maeda;Jun Fang;Takao Inutsuka;Yasunori Kitamoto

  • Therapeutic strategies by modulating oxygen stress in cancer and inflammation.

    Jun Fang;Takahiro Seki;Hiroshi Maeda

Frequent Co-Authors

Takaaki Akaike
Takaaki Akaike Tohoku University
Kazumasa Togano
Kazumasa Togano National Institute for Materials Science
Hiroaki Kumakura
Hiroaki Kumakura National Institute for Materials Science
Nakao Ishida
Nakao Ishida Tohoku University
Hitoshi Kitaguchi
Hitoshi Kitaguchi National Institute for Materials Science
Peter Valent
Peter Valent Medical University of Vienna
Masaki Otagiri
Masaki Otagiri Sojo University
Masayuki Ando
Masayuki Ando Kumamoto University
Winfried F. Pickl
Winfried F. Pickl Medical University of Vienna
Karel Ulbrich
Karel Ulbrich Czech Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open up a wide range of online degrees and career options within healthcare, research, and administration. For those interested in combining science with business, pursuing a cheap online mba healthcare administration is a strong option to develop leadership skills tailored to the medical field.

If you prefer a technical or data-driven role, the healthcare industry is seeing rising demand for professionals certified in coding and data management. Understanding the differences in pathways—such as becoming a certified coding specialist (ccs)—is crucial, as each certification can influence career prospects and salary.

Medical coding is another fast-growing career, and you may wonder about medical coding jobs salary and the necessary qualifications. Entry usually requires dedicated training and certification, and salaries can be competitive depending on your experience and location.

Before choosing a path, consider the medical billing and coding outlook, as job stability, remote work options, and career advancement can differ based on your chosen specialty and educational background.

Best Scientists Citing Hiroshi Maeda

Trending Scientists

Recently Published Articles